Literature DB >> 29864894

MiR-876-5p suppresses cell proliferation by targeting Angiopoietin-1 in the psoriasis.

Rongna A1, Pei Yu2, Siyu Hao2, Yuzhen Li3.   

Abstract

Psoriasis is an autoimmune disease characterized by abnormal differentiation and hyper-proliferation of epidermal keratinocytes. The object of the study is to investigate the role of miRNA-876-5p in psoriasis. It reported that MicroRNAs (miRNAs) played roles in the malignant progression in psoriasis development. The expression of miR-876-5p was found to be down-regulated in psoriasic tissue and blood of patients. The luciferase assay verified the targeting role of miR-876-5p to 3'UTR of Angiopoietin-1 (Ang-1). Proliferation of psoriasic cells were inhibited by miR-876-5p and hold on G0/G1 phase. Further studies showed that miR-876-5p suppressed proliferation by restraining the expression of Ang-1, which would regulate the phosphorylation level of PI3K, AKT, mTOR and ERK in psoriasic cells. Invasion and adhesion, serving as important behavioral traits of epidermal keratinocytes cells, were suppressed by excessive miR-876-5p in psoriasic cells also. MiR-876-5p would be expected to be biomarker and potential therapeutic targets for the treatment of psoriasis.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Ang-1; Migration; Proliferation; Psoriasis; miR-876-5p

Mesh:

Substances:

Year:  2018        PMID: 29864894     DOI: 10.1016/j.biopha.2018.04.145

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  11 in total

1.  Single cell transcriptional zonation of human psoriasis skin identifies an alternative immunoregulatory axis conducted by skin resident cells.

Authors:  Yuzhen Li; Yizhou Hu; Yuge Gao; Xinyu Yao; Yumeng Zhai; Li Li; Huini Li; Xianqi Sun; Pei Yu; Tiankuo Xue
Journal:  Cell Death Dis       Date:  2021-05-06       Impact factor: 8.469

Review 2.  Epidermal mTORC1 Signaling Contributes to the Pathogenesis of Psoriasis and Could Serve as a Therapeutic Target.

Authors:  Claudia Buerger
Journal:  Front Immunol       Date:  2018-11-30       Impact factor: 7.561

3.  Pharmacokinetics and Safety of Icotinib Hydrochloride Cream in Patients with Mild to Moderate Chronic Plaque Psoriasis: A Randomized Double-Blind Vehicle-Controlled Phase 1 Study.

Authors:  Lunfei Liu; Honggang Lou; Jiong Zhou; Ying Shen; Min Zheng; Zourong Ruan
Journal:  Biomed Res Int       Date:  2019-05-02       Impact factor: 3.411

4.  Construction of a lncRNA-miRNA-mRNA network to determine the regulatory roles of lncRNAs in psoriasis.

Authors:  Qianqian Zhou; Qian Yu; Yu Gong; Zhicui Liu; Hui Xu; Yao Wang; Yuling Shi
Journal:  Exp Ther Med       Date:  2019-09-23       Impact factor: 2.447

5.  SNHG17 drives malignant behaviors in astrocytoma by targeting miR-876-5p/ERLIN2 axis.

Authors:  Fengping Du; Qian Hou
Journal:  BMC Cancer       Date:  2020-09-03       Impact factor: 4.430

Review 6.  MicroRNAs in Several Cutaneous Autoimmune Diseases: Psoriasis, Cutaneous Lupus Erythematosus and Atopic Dermatitis.

Authors:  Sandra Domingo; Cristina Solé; Teresa Moliné; Berta Ferrer; Josefina Cortés-Hernández
Journal:  Cells       Date:  2020-12-10       Impact factor: 6.600

Review 7.  Advances in the pathogenesis of psoriasis: from keratinocyte perspective.

Authors:  Xue Zhou; Youdong Chen; Lian Cui; Yuling Shi; Chunyuan Guo
Journal:  Cell Death Dis       Date:  2022-01-24       Impact factor: 9.685

Review 8.  Predominant Role of mTOR Signaling in Skin Diseases with Therapeutic Potential.

Authors:  Fani Karagianni; Antreas Pavlidis; Lina S Malakou; Christina Piperi; Evangelia Papadavid
Journal:  Int J Mol Sci       Date:  2022-02-01       Impact factor: 5.923

9.  MicroRNA Alterations Induced in Human Skin by Diesel Fumes, Ozone, and UV Radiation.

Authors:  Giuseppe Valacchi; Erika Pambianchi; Simona Coco; Alessandra Pulliero; Alberto Izzotti
Journal:  J Pers Med       Date:  2022-01-28

Review 10.  The Role of MicroRNAs in Epidermal Barrier.

Authors:  Ai-Young Lee
Journal:  Int J Mol Sci       Date:  2020-08-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.